BIONTECH SE's ticker is BNTX and the CUSIP is 09075V102. A total of 253 filers reported holding BIONTECH SE in Q3 2023. The put-call ratio across all filers is 1.08 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7,766,023 | -73.9% | 71,484 | -74.1% | 0.01% | -73.1% |
| Q2 2023 | $29,751,878 | -39.1% | 275,659 | -29.7% | 0.05% | -42.9% |
| Q1 2023 | $48,817,608 | -16.5% | 391,889 | +0.7% | 0.09% | -30.0% |
| Q4 2022 | $58,438,434 | +38.0% | 389,019 | +23.9% | 0.13% | +38.3% |
| Q3 2022 | $42,352,000 | +299.5% | 313,992 | +341.6% | 0.09% | +308.7% |
| Q2 2022 | $10,601,000 | -57.4% | 71,104 | -51.3% | 0.02% | -54.0% |
| Q1 2022 | $24,882,000 | +4.2% | 145,886 | +58.1% | 0.05% | +11.1% |
| Q4 2021 | $23,879,000 | -33.6% | 92,291 | -30.0% | 0.04% | -40.0% |
| Q3 2021 | $35,985,000 | +10.8% | 131,850 | -9.1% | 0.08% | +4.2% |
| Q2 2021 | $32,482,000 | +264.7% | 145,085 | +77.9% | 0.07% | +227.3% |
| Q1 2021 | $8,906,000 | +59.3% | 81,560 | +18.9% | 0.02% | +57.1% |
| Q4 2020 | $5,591,000 | +52.9% | 68,579 | +29.9% | 0.01% | +27.3% |
| Q3 2020 | $3,656,000 | +33.2% | 52,814 | +28.4% | 0.01% | +22.2% |
| Q2 2020 | $2,744,000 | – | 41,119 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 148,674 | $16,151,943 | 19.26% |
| Quinn Opportunity Partners LLC | 659,383 | $71,635,369 | 9.22% |
| Systrade AG | 50,000 | $5,432,000 | 4.70% |
| Crocodile Capital Partners GmbH | 29,586 | $3,214,223 | 3.03% |
| ALTRINSIC GLOBAL ADVISORS LLC | 700,421 | $76,093,737 | 2.94% |
| Temasek Holdings (Private) Ltd | 4,518,080 | $490,844,211 | 2.92% |
| PARUS FINANCE (UK) Ltd | 25,662 | $2,787,920 | 1.74% |
| FLOSSBACH VON STORCH AG | 3,513,215 | $381,675,678 | 1.68% |
| AtonRa Partners | 4,707 | $511,368 | 1.07% |
| Baader Bank Aktiengesellschaft | 135,093 | $14,617,456 | 0.99% |